Health News Releases

  • Today January 31
October 26, 2022 17:25
Merck Showcases Depth of MS Portfolio at ECTRIMS Supporting Commitment to Advancing MS Care
Merck, a leading science and technology company, today announced it will present 39 abstracts at the 38th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS),
October 26, 2022 16:57
Merck Highlights New Data for Evobrutinib, First BTKi to Demonstrate Sustained Clinical Benefit for People with RMS through Three and a Half Years of Treatment
Merck, a leading science and technology company, today announced findings which demonstrated that annualized relapse rates (ARR) remained low and Expanded Disability Status Scale (EDSS) scores were st
October 25, 2022 16:55
Ferring Presents Seven New Analyses at ACG 2022 for RBX2660, Its Investigational Microbiota-Based Live Biotherapeutic
Ferring Pharmaceuticals today announced the presentation at the American College of Gastroenterology (ACG) 2022 Annual Scientific Meeting of seven analyses for RBX2660, an investigational microbiota-b
October 25, 2022 14:55
Neuraptive Therapeutics Announces Key Organizational Updates to Support the Company’s Advancements in Nerve Repair
Neuraptive Therapeutics, Inc., a biotechnology company dedicated to developing novel therapeutics and medical products to address the unmet needs of physicians and patients impacted by peripheral nerv
October 25, 2022 13:30
DentalMonitoring Now Offers Smart STL[*] Powered by AI-driven Technology
DentalMonitoring now offers Smart STL[*] powered by AI-driven technology. The company brings the only platform in the oral healthcare industry capable of creating updated STL files 100% remotely[*]. T
October 25, 2022 10:50
Urethral Stricture: BEES-HAUS Cell Therapy Approach Proven With Cell Engraftment by Urologists of Edogawa Hospital, Japan, Holds Potential to Prevent Recurrence.
Urethral stricture, blocking the passage of urine from the bladder in men, could be solved by BEES-HAUS cell therapy, a novel autologous buccal mucosal cell-based approach as reported by Dr. Akio Hori
October 25, 2022 10:30
Biotechs, Developing Countries Vaccine Manufacturers and Pharma Unite Behind a Proposal to G20 and G7 Offering a Practical Solution for Better Access to Vaccines for Future Pandemics
The Biotechnology Innovation Organization (BIO), Developing Countries Vaccine Manufacturers’ Network (DCVMN) and the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) h
October 24, 2022 18:00
GQC Is Born: the First Start-up, Federated by PQE Group, to Support Medical Cannabis
The world's first start-up to support pharmaceutical companies in every aspect of medical cannabis development and distribution is Italian. Named GQC - Glocal Quality Cannabis, it is one of the federa
October 21, 2022 11:10
LEO Pharma Announces European Commission Approval of Adtralza® (tralokinumab) for the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents
NOT FOR DISTRIBUTION IN THE UK OR IRELAND LEO Pharma A/S, a global leader in medical dermatology, today announced that the European Commission (EC) has extended the marketing authorization for Adtr
October 21, 2022 11:00
Ferring Presents New Subgroup Analyses of Health-Related Quality of Life and Safety and Efficacy Data at IDWeek 2022 for RBX2660, Its Investigational Microbiota-based Live Biotherapeutic
Ferring Pharmaceuticals today announced the presentation of two subgroup analyses at Infectious Disease Week (IDWeek) 2022 that further characterize RBX2660, an investigational microbiota-based live b
October 21, 2022 10:40
University of Tübingen and Boehringer Ingelheim Join Forces to Lead AI and Data Science R&D for New Medical Breakthroughs
University of Tübingen, a leading member of Cyber Valley, Europe’s largest Artificial Intelligence (AI) research consortium and Boehringer Ingelheim launch an AI and data science fellowship program fo
October 21, 2022 10:33
Takeda Enters Collaboration and Licensing Agreement with Zedira and Dr. Falk Pharma to Develop First-in-Class Celiac Disease Therapy
Takeda (TSE:4502/NYSE:TAK), Zedira and Dr. Falk Pharma GmbH today announced a collaboration and licensing agreement to develop ZED1227/TAK-227, a Phase 2b investigational therapy for the treatment of
October 20, 2022 16:25
Approval of extension of exemptions from SIX disclosure and publicity obligations
Regulatory News: AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR Vifor Pharma AG (Vifor) announced today that by decision dated October 19, 2022, SIX Exchange Regulation AG (SER) has approved an exte
October 19, 2022 17:00
Global Excel Management Announces Strategic Partnership With Flightcare Global
Global Excel Management Inc. (Global Excel), a leading supplier of global healthcare risk management solutions, is pleased to announce that it has acquired a majority ownership in Blue Sky Health Pty
October 19, 2022 11:50
Lysando AG and Amicogen Inc. Sign General Development Agreement
Lysando AG - market leader in the field of antimicrobial proteins - has signed a general development agreement with Amicogen Inc., a publicly traded biotechnology company and CDMO headquartered in Sou
October 18, 2022 17:30
Eucure Biopharma, a Subsidiary of Biocytogen Pharmaceuticals, Licenses OX40 Antibody (YH002) and Multiple Active Ingredients to Syncromune for the Development and Commercialization of Intratumoral Immunotherapy
Eucure (Beijing) Biopharma Co., Ltd. (“Eucure”), a wholly owned subsidiary of Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”), announced today that the company has entered into a worldwi
October 18, 2022 11:50
Single Use Support Launches IRIS Single-Use Bag Line
Austrian solution provider Single Use Support GmbH is expanding its product portfolio with new single-use bioprocess containers under the brand name IRIS. The pioneering company leverages its know-how
October 18, 2022 10:30
ESAB Corporation Acquires Ohio Medical
ESAB Corporation (“ESAB” or the “Company”) (NYSE: ESAB), a world leader in fabrication and gas control technology, announced today that it has acquired Ohio Medical, LLC (“Ohio Medical”), a global lea
October 17, 2022 11:35
CHMP recommends conditional marketing authorization for Spesolimab as first in class treatment option for generalized pustular psoriasis flares
The European Medicine Agency’s Committee for Medicinal Products for Human Use (CHMP) recommended the granting of a conditional market authorization[*] for Boehringer Ingelheim’s spesolimab as first in
October 17, 2022 11:30
Takeda Receives Positive CHMP Opinion Recommending Approval of Dengue Vaccine Candidate in EU and Dengue-Endemic Countries
Takeda (TSE:4502/NYSE:TAK) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recommended the approval of Takeda’s dengue vaccine can
October 14, 2022 10:20
Wyss Center for Bio and Neuroengineering: New Horizons in Neural Recording Systems
A new whitepaper, released by the Wyss Center for Bio and Neuroengineering, reveals the first neural signals recorded by the ABILITY brain-computer interface (BCI) system. It also lays out the plan fo
Iodine prills – produced by SQM
October 14, 2022 09:35
GE Healthcare Announces Multi-Year Agreement with SQM to Secure Iodine Supply for Contrast Media
GE Healthcare’s Pharmaceutical Diagnostics business has announced a long-term agreement with Chile-based mining company, Sociedad Quimica y Minera de Chile S.A. (SQM) (NYSE: SQM; Santiago Stock Exchan
Mr. Tan Kong Hwee, Executive Vice President of the Singapore Economic Development Board (EDB) and Fl
October 13, 2022 16:30
Galderma Announces Intention to Expand Manufacturing and Innovation Footprint in Asia-Pacific
Reaffirming its bold ambition to become the leading dermatology company in the world, Galderma today announced its intention to expand its manufacturing and innovation footprint in the Asia-Pacific re
Trueman Man Clinic Network Demonstrates Its Excellence in Gynecomastia Surgery in Korea with 25,700 Operations
October 13, 2022 13:30
Trueman Man Clinic Network Demonstrates Its Excellence in Gynecomastia Surgery in Korea with 25,700 Operations
Trueman Man Clinic Network announced that it has performed more than 25,700 gynecomastia operations as of September 2022 from 2010. Trueman Man Clinic Network is a renowned hospital for male-specific
October 12, 2022 17:20
Approval of delisting of Vifor Pharma AG's registered shares
Regulatory News: AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR Vifor Pharma AG (SWX:VIFN) (Vifor) announced today that Vifor has received approval for the delisting of the totality of Vifor's regis
25 per page50 per page75 per page100 per page